76 Life-Saving Drugs to get Costlier

Abbreviated New Drug Application (ANDA) www.ambitionias.com
  • The Department of Revenue has issued a notification on January 28, withdrawing exemption from import duty on a number of drugs, including cancer and other lifesaving drugs.
  • Biocon Chairperson and Managing Director Kiran Mazumdar Shaw said, “This will result in excise duties to the extent of over 22 per cent, which will make 76 life-saving drugs more expensive.
  • This will adversely impact the government’s aim of making healthcare affordable and accessible to patients in India.”